Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2005
03/15/2005US6867217 Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
03/15/2005US6867214 Quinazoline derivatives and pharmaceutical applications thereof
03/15/2005US6867209 Indole-type derivatives as inhibitors of p38 kinase
03/15/2005US6867207 IL-5 inhibiting 6-azauracil derivatives
03/15/2005US6867206 6-carboxyphenyldihydropyridazinone derivatives and use thereof
03/15/2005US6867205 Useful for the treatment and/or prophylaxis of diseases associated with dipeptidyl peptidase, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance
03/15/2005US6867203 Cinnamide derivatives with aryl sulfide functionality; cerebral vasospasm
03/15/2005US6867201 For therapy of abnormal cell growth, such as cancer, in mammals
03/15/2005US6867200 Anticancer agents; anticoagulants
03/15/2005US6867184 Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors
03/10/2005WO2005022161A1 Chemiluminescent compounds
03/10/2005WO2005021539A1 Benzimidazolone compounds having 5-ht4 receptor agonistic activity
03/10/2005WO2005021536A2 Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as dpp-iv inhibitors
03/10/2005WO2005021533A1 Substituted isoquinoline derivatives and methods of use
03/10/2005WO2005021532A1 Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of use
03/10/2005WO2005021531A1 N-substituted benzimidazolyl c-kit inhibitors
03/10/2005WO2005021530A1 8- (1-piperazinyl)- quinoline derivatives and their use in the treatment of cns disorders
03/10/2005WO2005021529A1 Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5
03/10/2005WO2005021528A1 2-substituted benzimidazole derivatives as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
03/10/2005WO2005021523A1 Piperazine substituted compounds used as calcium channel blockers
03/10/2005WO2005021509A1 Quinoline derivatives as neutrophil elastase inhibitors and their use
03/10/2005WO2005021508A1 Phenyl or pyridyl amide compounds as prostaglandin e2 antagonists
03/10/2005WO2005021500A1 Cyclic derivatives as modulators of chemokine receptor activity
03/10/2005WO2005021495A2 Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones
03/10/2005WO2005020996A1 Method of stabilizing lipid-rich plaque and method of preventing rupture thereof
03/10/2005WO2005020899A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity
03/10/2005WO2005020897A2 Compositions and methods for the treatment of disease associated with trp-p8 expression
03/10/2005WO2004112793B1 Guanidino-substituted quinazolinone compounds as mc4-r agonists
03/10/2005WO2004096795A3 C-fms kinase inhibitors
03/10/2005WO2004096128A3 Hiv integrase inhibitors
03/10/2005WO2004071447B1 Substituted azole derivatives as therapeutic agents
03/10/2005WO2004012733A9 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy
03/10/2005US20050054856 An addition polymerization catalyst of a cationic transition metal complex of a neutral bidentate ligand including a pyrole ring and an anion or nickelbis(1,5-cyclooctadiene), tri(pentafluorophenyl)borane and the neutral bidentate ligand; heat resistance; stability; steric hinderance for process control
03/10/2005US20050054715 Vinyl phenyl derivatives as glk activators
03/10/2005US20050054713 3-Substituted oxindole beta3 agonists
03/10/2005US20050054712 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators
03/10/2005US20050054710 Inhibits effect on various receptor tyrosine kinases and CDK (cyclin dependent kinases) complexes and on the proliferation of endothelial cells and various tumor cells
03/10/2005US20050054709 3a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine-derived neuropeptideYreceptors ligands useful in the treatment of obesity and other disorders
03/10/2005US20050054706 N-substituted pyrroles, pyrazoles, imidazoles, triazoles and tetrazoles used for treating and preventing cancer, inflammation, autoimmune diseases, respiratory system disorders, septic shock, pain, preterm labor, as dietetics and sexual disorders, and disorders associated with MAP kinases
03/10/2005US20050054696 Indole compounds and medicinal use thereof
03/10/2005US20050054686 Imidazole derivatives
03/10/2005US20050054679 For therapy of psychiatric and neurological disorders
03/10/2005US20050054678 Nitrogenous five-membered ring compounds
03/10/2005US20050054672 Quinolinone derivatives
03/10/2005US20050054670 Angiogenesis inhibitors; anticancer agents; antiinflammatry agents
03/10/2005US20050054668 Antagonists of MCP-1 function and methods of use thereof
03/10/2005US20050054662 Quinazoline derivatives as antitumor agents
03/10/2005US20050054656 Therapy for obesity, eating disorders, psychological disorders, antidepressants, central nervous system disorders
03/10/2005US20050054654 VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
03/10/2005US20050054651 Compositions and methods for the treatment of disease associated with Trp-p8 expression
03/10/2005US20050054643 Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
03/10/2005US20050054639 Viricide against human t-cell leukemia/lymphoma virus infections
03/10/2005US20050054638 Anticancer agents
03/10/2005US20050054631 Substituted indoles as inhibitors of poly (ADP-ribose) polymerase (PARP)
03/10/2005US20050054628 2-Substituted benzimidazole piperidines analogs as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
03/10/2005US20050054627 Cyclic derivatives as modulators of chemokine receptor activity
03/10/2005US20050054626 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
03/10/2005CA2537487A1 Piperazine substituted compounds used as calcium channel blockers
03/10/2005CA2537141A1 Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5
03/10/2005CA2537123A1 New compounds
03/10/2005CA2535896A1 N-substituted benzimidazolyl c-kit inhibitors
03/10/2005CA2535265A1 Compositions and methods for the treatment of disease associated with trp-p8 expression
03/09/2005EP1512686A1 Imidazonaphthyridines and their use in inducing cytokine biosythesis
03/09/2005EP1512685A1 Imidazonaphthyridines and their use in inducing cytokine biosythesis
03/09/2005EP1511744A2 Bis-benzimidazoles and related compounds as potassium channel modulators
03/09/2005EP1511743A1 Pyrazole-derivatives as p38 kinase inhibitors
03/09/2005EP1511742A1 Kinase inhibitors
03/09/2005EP1511741A1 Ester derivatives of a decahydroisoquinoline-3-carboxylic acid as analgestics
03/09/2005EP1511737A1 Aryloximes
03/09/2005EP1511733A2 Pyrazole and pyrrole carboxamide insecticides
03/09/2005EP1511730A2 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
03/09/2005EP1511727A2 Aromatic sulfones and their medical use
03/09/2005EP1511488A2 Human adam-10 inhibitors
03/09/2005EP1511482A1 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
03/09/2005EP1511385A1 Insecticidal amides with nitrogen-containing benzo-fused bicyclic ring systems
03/09/2005EP1370549A4 Methods for the preparation of mirtazapine intermediates
03/09/2005EP1202969B1 Biphenyl derivatives, production thereof and use as medicines
03/09/2005EP1123918B1 Aromatic amine derivatives, process for the preparation thereof and agents containing the same
03/09/2005EP1057814B1 Tetrahydrobenzindole derivatives
03/09/2005EP1018008B1 Method of identification of leads or active compounds
03/09/2005EP0869792B1 4-substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
03/09/2005EP0817627B1 Protein kinase c inhibitors
03/09/2005CN1592745A Therapeutic chromone compounds
03/09/2005CN1592743A Inhibitors of glycogen synthase kinase 3
03/09/2005CN1592742A Neurotensin active 2, 3-diaryl-pyrazolidine derivatives
03/09/2005CN1592741A Antiretroviral pyridine and quinoline derivatives
03/09/2005CN1592740A Process for the synthesis of amine ethers from secondary amino oxides and its use
03/09/2005CN1592739A Novel piperidine based MCH antagonists for treatment of obesity and CNS disorders
03/09/2005CN1592623A Acetylene derivatives having human matabotropic glutamate receptor antagonistic activity
03/09/2005CN1590378A Quinoxaline derivative and its preparation method and use
03/09/2005CN1590375A TNF-alpha prodn. inhibitors
03/09/2005CN1590374A TNF-alpha prodn. inhibitors
03/09/2005CN1192032C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
03/09/2005CN1192028C Heterocyclic substituted aminoazacycles useful as central nervous system agents
03/09/2005CN1192021C 3-azabicyclo [3.1.0] hexane derivatives as opiate receptors ligands
03/09/2005CN1192020C Antidiabetic agents
03/09/2005CN1192018C Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds
03/08/2005US6864380 Antiinflammatory agents; asthma; antiallergens; autoimmune diseases; antiarthritic agents
03/08/2005US6864368 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases
03/08/2005US6864277 Brain diosrders; cardiovascular disorders; central nervous system disorders; psychological disorders
1 ... 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 ... 1080